OPSCC
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Objective Response Rate of Ivonescimab With Chemotherapy in Locally Advanced Resectable Oral and Oropharyngeal Squamous Cell Carcinoma (NCT07686575) | Zhujiang Hospital | 2026-01-26 |
| Phase II Clinical Trial of De-Intensified Therapy in Human Papilloma Virus (HPV) Associated Oropharyngeal Squamous Cell Carcinoma (NCT06759155) | University of Vermont Medical Center | 2025-01-01 |
Track OPSCC automatically
Every clearance here is in the API, with alerts when new ones post.